During the past decade, Raffaele Marfella conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Raffaele Marfella" are "Heart Failure" (5 trials), "Diabetes Mellitus" (3 trials), "Coronary Artery Disease" (2 trials), "Diabetes" (2 trials) and "STEMI" (2 trials). Many other conditions were trialed in "Raffaele Marfella" in a lesser frequency.

Most popular intervention types in "Raffaele Marfella" are "Drug" (6 trials), "Other" (5 trials), "Device" (4 trials), "Procedure" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Incretins" (2 trials), "Cardiac Resynchronization therapy defibrillator device" (1 trials), "Incretin Effect" (1 trials), "PCI and DES stenting" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Raffaele Marfella" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Raffaele Marfella". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Raffaele Marfella, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Raffaele Marfella, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".